Zhaoke Ophthalmology Pharmaceutical

Zhaoke Ophthalmology Pharmaceutical (6622 HK)

Health CareChina
Zhaoke Ophthalmology Pharmaceutical operates as a pharmaceutical company. The Company engages in the business of researching, developing and commercialising ophthalmological drugs. Zhaoke Ophthalmology markets its products throughout China and ASEAN marketplace.
bullishZhaoke Ophthalmology Pharmaceutical18 Feb 2021 01:03

Zhaoke Ophthalmology: Bringing Focus to China

Zhaoke Ophthalmology is a pre-revenue pharmaceutical company specializing in ophthalmic drugs for China that has filed to list on the HKEX. Lee's...

bearishZhaoke Ophthalmology Pharmaceutical09 Mar 2021 09:28

Pre-IPO Zhaoke Ophthalmology Pharmaceutical - It Remains to Be Seen How to Find Its Way Out

The article analyzed Zhaoke Ophthalmology in terms of pipeline, competitive landscape, financial position and also included concerns for the future...

bearishLepu Biopharma10 Feb 2022 16:54

Lepu Biopharma (乐普生物科技) IPO: Sentiment Cooled Down

Downsized deal amid cooled sentiment for Chapter 18A, we think the valuation of Lepu Biopharm is not attractive for investors.

bearishZhaoke Ophthalmology Pharmaceutical28 Apr 2021 11:09

Zhaoke Ophthalmic (兆科眼科) IPO Trading: Strong Cornerstone Doesn't Save the Deal

We re-iterate our differentiated bearish view with the deal. The deal received lukewarm interests from retail and institutional investors. We would...

bearishZhaoke Ophthalmology Pharmaceutical19 Apr 2021 07:26

Zhaoke Opthalmology IPO Valuation: Overpriced

Some of the company’s drug candidates have the potential to become market-leading products, however, Zhaoke does not have any prior experience in...